When the COVID-19 pandemic hit, the quick onset of social distancing and varied forms of shelter in place regulations impacted the pharmaceutical industry in a multitude of ways. Some of the biggest impacts seen included: all forms of personal sales activities were suspended; for all non-essential / critical therapy needs HCPs were requiring patients toRead More
It’s easy to lose touch in times like these. Consumer behaviors have changed. Some of this will be short-term while undoubtedly some changes will be longer-term. But brands will go on. Consumer preferences and loyalties will persist. How brands behave in these challenging times will play a large role in that equation. But how shouldRead More
Actioning and optimizing your commercial investments against the evolving recovery and consumer demand curve on a real-time basis Most marketing driven organizations are working through what will effectively be two major cross-waves of planning. The first wave is rolling in now and is all about maximizing revenue and profits for the balance of the yearRead More
We are reaching out to you as business partners to ensure that you know Ipsos MMA is taking the spread of COVID-19 extremely seriously. We are working hard to ensure that we are able to service your business while simultaneously taking all appropriate actions to protect our employees’ health and well-being. While the Coronavirus situationRead More
Ensuring marketers can holistically optimize their investments by overcoming the challenges of limited data sharing By Robert Cardarelli, SVP at Ipsos MMA Too often these days, whenever you hear about multi-touch attribution (MTA) there is a LOT of doubt in the marketer’s mind as to whether it will deliver on its promise. Themes like “blackRead More